Post hoc analysis of 54 patients with COPD from the DISARM trial: the 33% with mixed granulocytic airway inflammation had the lowest FEV1, most emphysema and highest exacerbation rates, with raised type 1 and type 2 immune and tissue remodelling gene expression in BAL.
Secondary analysisn = 54
Leung et al. Clinical and transcriptomic characterization of mixed granulocytic phenotype in chronic obstructive pulmonary disease